About Trugenomix Health
Trugenomix Health is a private company based in Gaithersburg, Maryland. It has reported $2,925,000 raised in six offerings on Form D since November 2020. Its chief executive is Hubert Cathlin, Jr..
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 19, 2025 | Aug 26, 2025 | $250,000of $500K target | 1 | $250K | DebtRule 506(b) | Form D ↗ |
| Oct 4, 2023 | Dec 11, 2023 | $1,000,000fully sold | 1 | $1.0M | DebtRule 506(b) | Form D ↗ |
| May 5, 2023 | May 19, 2023 | $1,000,000fully sold | 3 | $333K | DebtRule 506(b) | Form D ↗ |
| Feb 25, 2021 | Mar 25, 2021 | $100,000fully sold | 1 | $100K | DebtRule 506(b) | Form D ↗ |
| Jan 11, 2021 | Feb 8, 2021 | $500,000fully sold | 1 | $500K | DebtRule 506(b) | Form D ↗ |
| Oct 26, 2020 | Nov 16, 2020 | $75,000fully sold | 1 | $75,000 | DebtRule 506(b) | Form D ↗ |
| Total, six offerings | $2,925,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Trugenomix Health's Form D filed Aug 26, 2025.
DS
Dr. Pardis Sabetti
Director
HJ
Hubert Cathlin, Jr.
Chief Executive Officer and director
AN
Anne Naclerio
Director
TC
Tshaka Cunningham
Director
Earlier filings also listed H. Cathlin (executive officer and director, last listed Dec 2023) and Charles Cathlin (chief executive officer and director, last listed May 2023).